Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
01/1999
01/27/1999CN1206435A Method for transforming indica rice
01/27/1999CN1206421A Apolipoprotein Ez and treatment of alzheimer's disease
01/27/1999CN1206350A Hybrid with interferon-'alpha' and immunoglobulin Fc linkes through non-immunogenic peptide
01/27/1999CN1206045A Ferulic acid decarboxylase
01/27/1999CN1041831C Neurotrophic factors having altered receptor binding specificities
01/26/1999US5864032 Biotin derivative of an 2-(n,n-diisopropyl-o-nitrilopropyl-phosphoramidito),3-(3-aminopropyl) -glycerol; labels for synthetic oligonucleotides; hybridisation probes
01/26/1999US5864031 Process for preparing 5-dithio-modified oligonucleotides
01/26/1999US5864028 Degradation resistant mRNA derivatives linked to TNF-α ribozymes
01/26/1999US5864026 Systematic evolution of ligands by exponential enrichment: tissue selex
01/26/1999US5864021 Method and apparatus for the production of TGF-β and purified TGF-β compositions
01/26/1999US5864020 A monoclonal antibody specifically binds to a hepatoma transmembrane kinase receptor ligand having selective amino acid sequence
01/26/1999US5864019 Antigen-binding protein comprising: 3 or 4 vh domains; spacing polypeptide attached to c-terminal end of each vh domain; linkage polypeptide containing linkable residues attached to c-terminal end of each spacing polypeptide; vl domain
01/26/1999US5864018 Antibodies to advanced glycosylation end-product receptor polypeptides and uses therefor
01/26/1999US5864015 Hodgkin's disease associated molecules
01/26/1999US5864013 Materials for the production of nanometer structures and use thereof
01/26/1999US5863904 Methods for treating cancers and restenosis with P21
01/26/1999US5863893 Anticoagulants
01/26/1999US5863891 Protein fragments joined by peptide bonds
01/26/1999US5863804 Monoclonal or polyclonal antibodies obtained by administering to an animal a synthetic peptide or a recombinant protein fragment having a partial sequence of t-cadherin, isolating from animal's serum
01/26/1999US5863801 Cassette in which all chemical manipulation occur, which includes a storage/transfer strips; can prepare nucleic acid preperation from upto 24 different biological samples at a time
01/26/1999US5863798 Attachment enhanced 293 cells
01/26/1999US5863797 Gene fusion encoding a hypersecretor protein
01/26/1999US5863796 Immunizing a mammal with specific polypeptide and collecting the antibody
01/26/1999US5863795 Nucleic acids that encode peptides which modulate apoptosis
01/26/1999US5863794 A nucleic acid sequence flanked at either end with integration promotion sequences designed to target integration of the vector into a selected site of the genome of a cell; gene therapy, bone marrow transplantation
01/26/1999US5863791 For use in polymerase chain reaction
01/26/1999US5863787 Kaposi's sarcoma-associated herpesvirus (KSHV) glycoprotein B (GB) and uses thereof
01/26/1999US5863786 Nucleic acid encoding modified human tnfα (tumor necrosis factor alpha) receptor
01/26/1999US5863784 Obtained by site-directed mutagenesis with recombinant beta-amylase gene coding 531 amino acids; substitutions were met181 with leu, ser291 with ala, ile293 with val, ser346 with pro, ser347 with pro, gln348, with asp, ala372 with ser
01/26/1999US5863783 Improving the break-down of plant cell walls which leads to better utilization of the plant nutrients, removing lignins and terpenoids from the cellulose and hemicellulose wood for papermaking, improving the clarity of fruit, vegetable juice
01/26/1999US5863780 A polynucleotide sequence encodes human protein kinase polypeptide; culture product
01/26/1999US5863779 UBC7-like ubiquitin-conjugating enzyme
01/26/1999US5863777 DNA encoding alanyl tRNA synthetase from streptococcus pneumonine
01/26/1999US5863775 Control of parasites
01/26/1999US5863774 Cell ablation using trans-splicing ribozymes
01/26/1999US5863772 Discriminating animal and plant individuals on the basis of a difference in dna sequence, using dna oligonucleotide primer having a symmetrical base sequence, producing amplified dna fragments, separating by electrophoresis, silver staining
01/26/1999US5863770 Stable meterologous propagation of CFTR protein variant cDNA
01/26/1999US5863769 DNA encoding interleukin-1 receptor antagonist (IL-1raβ)
01/26/1999US5863767 Keratinocyte growth factor fragment lacks the first 23 amino acid residues of the n-terminus of mature, full-length kgf; treatment of hyperproliferative disease of epidermis
01/26/1999US5863766 Isolated, pure polynucleotide encoding a polypeptide for treating vesicle trafficking, immunological, and neoplastic disorders.
01/26/1999US5863765 Connecting nucleotide sequences, transformation, cultures and cleavage of peptide sites
01/26/1999US5863764 DNA encoding a human membrane protein
01/26/1999US5863763 Insect neuropeptides
01/26/1999US5863762 Screening for antifungal agents
01/26/1999US5863759 Process for the production of protein products in aspergillus
01/26/1999US5863757 An expression vector comprising polynucleotide having an open reading frame operably linked to a promoter and encoding a specific polypeptide
01/26/1999US5863756 Utilize recombinant pace 4 and 4.1, mammalian endopeptidases that are specific for dibasic amino acid sites; therapeutic compositions and methods employing pace 4 or 4.1 or their inhibitors are also provided
01/26/1999US5863755 Nucleic acid encoding novel receptor-type phosphotyrosine phosphatase-κ
01/26/1999US5863745 Contacting cells targeted to be killed with a cytotoxic amount of an antibody-pe40 recombinant fusion protein, wherein said antibody is a single-chain fv fragment (scfv) and said pe40 is a pseudomonas exotoxin fragment
01/26/1999US5863739 Assay and kit for the detection of α platelet derived growth factor receptor
01/26/1999US5863738 Tissue morphogenic protein cell surface receptors
01/26/1999US5863737 Methods of using polypeptides encoding transcriptional activators
01/26/1999US5863736 Method, apparatus and computer program products for determining quantities of nucleic acid sequences in samples
01/26/1999US5863735 Human transmembrane 4 superfamily protein
01/26/1999US5863734 Method of treatment for obsessive-compulsive disorder
01/26/1999US5863733 Genetic engineering with cells, binding dna or rna to protein and domains
01/26/1999US5863732 Diagnostic kits for detection of target nucleic acid sequences
01/26/1999US5863730 Procedure for the polymerization of nucleic acid sequences and its applications
01/26/1999US5863726 Incubating cell sample in reaction mixture comprising telomerase substrate under condition such that telomerase can catalyze extension of telomerase substrate by addition of repeat sequences, replicating extended telomerase substrate
01/26/1999US5863724 Methods of screening for persistent hyperinsulinemic hypoglycemia of infancy
01/26/1999US5863722 Method of sorting polynucleotides
01/26/1999US5863717 Use of conserved oligonucleotide primers to amplify human papillomavirus DNA sequences
01/26/1999US5863542 Recombinant attenuated ALVAC canaryopox virus containing heterologous HIV or SIV inserts
01/26/1999US5863541 Proteins in cells
01/26/1999US5863537 Polypeptide comprising a variable region having the amino acid sequence of the variable region selected from the group consisting of h25d2h-1, h25d2h-2, h25d2h-3, h25d2h-4 and h25d2h-5
01/26/1999US5863528 Porcine cytokines
01/26/1999CA2151154C Production of heterologous proteins in filamentous fungi
01/26/1999CA2137639C Vaccine composition comprising autologous epidermal growth factor or a fragment or a derivate thereof having anti-tumor activity and use thereof in the therapy of malignant diseases
01/26/1999CA2005291C Feline infectious peritonitis virus diagnostic tools
01/26/1999CA2002862C Cloning and expression of a protein which modulates cellular response to type i interferon
01/26/1999CA1340333C Penicillium transformants and methods for their production
01/26/1999CA1340329C Superoxide dismutasee
01/26/1999CA1340328C Method for protein binding enzyme complementation assays
01/25/1999CA2238664A1 Novel regulator
01/25/1999CA2238655A1 Cdna clone my1 that encodes a novel human 7-transmembrane receptor
01/24/1999CA2238658A1 Novel grea
01/24/1999CA2211665A1 Coniferin beta-glucosidase cdna for modifying lignin content in plants
01/23/1999CA2238682A1 Novel asps
01/23/1999CA2238679A1 Novel phes
01/23/1999CA2238677A1 Novel iles
01/23/1999CA2238674A1 Novel tetracycline resistance protein
01/23/1999CA2238671A1 Novel bmru
01/23/1999CA2238667A1 Novel ferrichrome transport atp-binding protein
01/23/1999CA2238665A1 Novel reductase
01/23/1999CA2238663A1 Novel hiss
01/23/1999CA2238611A1 Novel lyss
01/23/1999CA2238608A1 Novel cyss
01/23/1999CA2211293A1 Recombinant lysostaphin analogs
01/21/1999WO1999002991A1 Antibodies and scfv immunotoxins specific to imported fire ants, and their application
01/21/1999WO1999002989A1 Chaperone fragments
01/21/1999WO1999002737A1 Method for the identification of synthetic cell- or tissue-specific transcriptional regulatory regions
01/21/1999WO1999002734A1 Reagents and methods useful for detecting diseases of the urinary tract
01/21/1999WO1999002733A1 Identification of molecular targets
01/21/1999WO1999002732A1 Antisense oligonucleotide inhibition of ras
01/21/1999WO1999002730A1 Method for detecting dna with probe pna
01/21/1999WO1999002729A1 Method of dna sequencing
01/21/1999WO1999002728A1 Characterising nucleic acids
01/21/1999WO1999002721A1 THE ESCHERICHIA COLI csrB GENE, RNA ENCODED THEREBY, AND METHODS OF USE THEREOF
01/21/1999WO1999002720A1 Enhanced scopolamine production in hyoscyamus plants and hairy root cultures
01/21/1999WO1999002719A1 Complementation trap